Atlas Trials

Single-Dose Phase 1 Study of TAK-792

Clinical trial NCT02448719 · COMPLETED

Trial details

NCT number
NCT02448719
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Male Adults Participants
Start date
2015-05-27
Primary completion
2016-01-28
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.